Mycobacterial enzymes as anti-tuberculosis drug targets and for use in selective protein modification
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. The mycobacterial cell wall is a characteristic component of mycobacteria and the enzymes involved in its biosynthesis are validated drug targets. Enoyl-ACP reductase (InhA) is involved in the elongation of mycolic acids. Is...
| Main Author: | |
|---|---|
| Published: |
University of Nottingham
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.588075 |